JACC. Heart failure, 2213-1779

Journal

  1. 2020
  2. Ezekowitz, J. A., O'Connor, C. M., Troughton, R. W., Alemayehu, W. G., Westerhout, C. M., Voors, A. A., Butler, J., Lam, C. S. P., Ponikowski, P., Emdin, M., Patel, M. J., Pieske, B., Roessig, L., Hernandez, A. F., & Armstrong, P. W. (2020). N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes. JACC. Heart failure, 8(11), 931-939. https://doi.org/10.1016/j.jchf.2020.08.008
  3. Nunez, J., Bayes-Genis, A., Revuelta-Lopez, E., ter Maaten, J. M., Minana, G., Barallat, J., Cserkoova, A., Bodi, V., Fernandez-Cisnal, A., Nunez, E., Sanchis, J., Lang, C., Ng, L. L., Metra, M., & Voors, A. A. (2020). Clinical Role of CA125 in Worsening Heart Failure A BIOSTAT-CHF Study Subanalysis. JACC. Heart failure, 8(5), 386-397. https://doi.org/10.1016/j.jchf.2019.12.005
  4. Cunningham, J. W., Vaduganathan, M., Claggett, B. L., Zile, M. R., Anand, I. S., Packer, M., Zannad, F., Lam, C. S. P., Janssens, S., Jhund, P. S., Kober, L., Rouleau, J., Shah, S. J., Chopra, V. K., Shi, V. C., Lefkowitz, M. P., Prescott, M. F., Pfeffer, M. A., McMurray, J. J., & Solomon, S. D. (2020). Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Election Fraction. JACC. Heart failure, 8(5), 372-381. https://doi.org/10.1016/j.jchf.2020.03.002
  5. Cunningham, J. W., Ferreira, J. P., Deng, H., Anker, S. D., Byra, W. M., Cleland, J. G. F., Gheorghiade, M., Lam, C. S. P., La Police, D., Mehra, M. R., Neaton, J. D., Spiro, T. E., van Veldhuisen, D. J., Greenberg, B., & Zannad, F. (2020). Natriuretic Peptide-Based Inclusion Criteria in a Heart Failure Clinical Trial Insights From COMMANDER HF. JACC. Heart failure, 8(5), 359-368. https://doi.org/10.1016/j.jchf.2019.12.009
  6. Li, J., Woodward, M., Perkovic, V., Figtree, G. A., Heerspink, H. J. L., Mahaffey, K. W., de Zeeuw, D., Vercruysse, F., Shaw, W., Matthews, D. R., & Neal, B. (2020). Mediators of the Effects of Canagliflozin on Heart Failure in Patients With Type 2 Diabetes. JACC. Heart failure, 8(1), 57-66. https://doi.org/10.1016/j.jchf.2019.08.004
  7. 2019
  8. PARAGON-HF Investigators, Chandra, A., Vaduganathan, M., Lewis, E. F., Claggett, B. L., Rizkala, A. R., Wang, W., Lefkowitz, M. P., Shi, V. C., Anand, I. S., Ge, J., Lam, C. S. P., Maggioni, A. P., Martinez, F., Packer, M., Pfeffer, M. A., Pieske, B., Redfield, M. M., Rouleau, J. L., ... Solomon, S. D. (2019). Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction The PARAGON-HF Trial. JACC. Heart failure, 7(10), 862-874. https://doi.org/10.1016/j.jchf.2019.05.015
  9. GENETIC-AF Trial Investigators, Piccini, J. P., Abraham, W. T., Dufton, C., Carroll, I. A., Healey, J. S., van Veldhuisen, D. J., Sauer, W. H., Anand, I. S., White, M., Wilton, S. B., Aleong, R., Rienstra, M., Krueger, S. K., Ayala-Paredes, F., Khaykin, Y., Merkely, B., Miloradovic, V., Wranicz, J. K., ... Connolly, S. J. (2019). Bucindolol for the Maintenance of Sinus Rhythm in a Genotype-Defined HF Population: The GENETIC-AF Trial. JACC. Heart failure, 7(7), 586-598. https://doi.org/10.1016/j.jchf.2019.04.004
  10. Martens, P., Dupont, M., Verbrugge, F. H., Damman, K., Degryse, N., Nijst, P., Reynders, C., Penders, J., Tang, W. H. W., Testani, J., & Mullens, W. (2019). Urinary Sodium Profiling in Chronic Heart Failure to Detect Development of Acute Decompensated Heart Failure. JACC. Heart failure, 7(5), 404-414. https://doi.org/10.1016/j.jchf.2019.02.011
  11. Wolsk, E., Kaye, D., Komtebedde, J., Shah, S. J., Borlaug, B. A., Burkhoff, D., Kitzman, D. W., Lam, C. S. P., van Veldhuisen, D. J., Ponikowski, P., Petrie, M. C., Hassager, C., Moller, J. E., & Gustafsson, F. (2019). Central and Peripheral Determinants of Exercise Capacity in Heart Failure Patients With Preserved Ejection Fraction. JACC. Heart failure, 7(4), 321-332. https://doi.org/10.1016/j.jchf.2019.01.006
  12. Savarese, G., Vedin, O., D'Amario, D., Uijl, A., Dahlstrom, U., Rosano, G., Lam, C. S. P., & Lund, L. H. (2019). Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure. JACC. Heart failure, 7(4), 306-317. https://doi.org/10.1016/j.jchf.2018.11.019
  13. Beldhuis, I. E., Myhre, P. L., Claggett, B., Damman, K., Fang, J. C., Lewis, E. F., O'Meara, E., Pitt, B., Shah, S. J., Voors, A. A., Pfeffer, M. A., Solomon, S. D., & Desai, A. S. (2019). Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease. JACC. Heart failure, 7(1), 25-32. https://doi.org/10.1016/j.jchf.2018.10.017
  14. 2018
  15. Savji, N., Meijers, W. C., Bartz, T. M., Bhambhani, V., Cushman, M., Nayor, M., Kizer, J. R., Sarma, A., Blaha, M. J., Gansevoort, R. T., Gardin, J. M., Hillege, H. L., Ji, F., Kop, W. J., Lau, E. S., Lee, D. S., Sadreyev, R., van Gilst, W. H., Wang, T. J., ... Ho, J. E. (2018). The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF. JACC. Heart failure, 6(8), 701-709. https://doi.org/10.1016/j.jchf.2018.05.018
  16. Damman, K., Gori, M., Claggett, B., Jhund, P. S., Senni, M., Lefkowitz, M. P., Prescott, M. F., Shi, V. C., Rouleau, J. L., Swedberg, K., Zile, M. R., Packer, M., Desai, A. S., Solomon, S. D., & McMurray, J. J. V. (2018). Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure. JACC. Heart failure, 6(6), 489-498. https://doi.org/10.1016/j.jchf.2018.02.004
  17. Cerbin, L. P., Ambrosy, A. P., Greene, S. J., Armstrong, P. W., Butler, J., Coles, A., DeVore, A. D., Ezekowitz, J. A., Hernandez, A. F., Metra, M., Starling, R. C., Tang, W., Teerlink, J. R., Voors, A. A., Wu, A., O'Connor, C. M., & Mentz, R. J. (2018). Is Time of the Essence? The Impact of Time of Hospital Presentation in Acute Heart Failure: Insights From ASCEND-HF Trial. JACC. Heart failure, 6(4), 298-307. https://doi.org/10.1016/j.jchf.2018.01.018
  18. Armstrong, P. W., Roessig, L., Patel, M. J., Anstrom, K. J., Butler, J., Voors, A. A., Lam, C. S. P., Ponikowski, P., Temple, T., Pieske, B., Ezekowitz, J., Hernandez, A. F., Koglin, J., & O'Connor, C. M. (2018). A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator The VICTORIA Trial. JACC. Heart failure, 6(2), 96-104. https://doi.org/10.1016/j.jchf.2017.08.013
  19. 2017
  20. Solomon, S. D., Rizkala, A. R., Gong, J., Wang, W., Anand, I. S., Ge, J., Lam, C. S. P., Maggioni, A. P., Martinez, F., Packer, M., Pfeffer, M. A., Pieske, B., Redfield, M. M., Rouleau, J. L., Van Veldhuisen, D. J., Zannad, F., Zile, M. R., Desai, A. S., Shi, V. C., ... McMurray, J. J. V. (2017). Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction Rationale and Design of the PARAGON-HF Trial. JACC. Heart failure, 5(7), 471-482. https://doi.org/10.1016/j.jchf.2017.04.013
  21. Tromp, J., Khan, M. A. F., Mentz, R. J., O'Connor, C. M., Metra, M., Dittrich, H. C., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Cleland, J. G. F., Givertz, M. M., Bloomfield, D. M., Van Veldhuisen, D. J., Hillege, H. L., Voors, A. A., & van der Meer, P. (2017). Biomarker Profiles of Acute Heart Failure Patients With a Mid-Range Ejection Fraction. JACC. Heart failure, 5(7), 507-517. https://doi.org/10.1016/j.jchf.2017.04.007
  22. Aimo, A., Vergaro, G., Ripoli, A., Bayes-Genis, A., Pascual Figal, D. A., de Boer, R. A., Lassus, J., Mebazaa, A., Gayat, E., Breidthardt, T., Sabti, Z., Mueller, C., Brunner-La Rocca, H-P., Tang, W. H. W., Grodin, J. L., Zhang, Y., Bettencourt, P., Maisel, A. S., Passino, C., ... Emdin, M. (2017). Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure. JACC. Heart failure, 5(4), 287-296. https://doi.org/10.1016/j.jchf.2016.12.016
  23. Ambrosy, A. P., Cerbin, L. P., Armstrong, P. W., Butler, J., Coles, A., DeVore, A. D., Dunlap, M. E., Ezekowitz, J. A., Felker, G. M., Fudim, M., Greene, S. J., Hernandez, A. F., O'Connor, C. M., Schulte, P., Starling, R. C., Teerlink, J. R., Voors, A. A., & Mentz, R. J. (2017). Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes Findings From the ASCEND-HF Trial. JACC. Heart failure, 5(1), 1-13. https://doi.org/10.1016/j.jchf.2016.09.012
  24. 2016
  25. Pang, P. S., Teerlink, J. R., Voors, A. A., Ponikowski, P., Greenberg, B. H., Filippatos, G., Felker, G. M., Davison, B. A., Cotter, G., Kriger, J., Prescott, M. F., Hua, T. A., Severin, T., & Metra, M. (2016). Use of High-Sensitivity Troponin T to Identify Patients With Acute Heart Failure at Lower Risk for Adverse Outcomes An Exploratory Analysis From the RELAX-AHF Trial. JACC. Heart failure, 4(7), 591-599. https://doi.org/10.1016/j.jchf.2016.02.009
  26. Zipes, D. P., Neuzil, P., Theres, H., Caraway, D., Mann, D. L., Mannheimer, C., Van Buren, P., Linde, C., Linderoth, B., Kueffer, F., Sarazin, S. A., DeJongste, M. J. L., & DEFEAT-HF Trial Investigators (2016). Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Systolic Heart Failure The DEFEAT-HF Study. JACC. Heart failure, 4(2), 129-136. https://doi.org/10.1016/j.jchf.2015.10.006
  27. Tang, W. H. W., Wu, Y., Grodin, J. L., Hsu, A. P., Hernandez, A. F., Butler, J., Metra, M., Voors, A. A., Felker, G. M., Troughton, R. W., Mills, R. M., McMurray, J. J., Armstrong, P. W., O'Connor, C. M., & Starling, R. C. (2016). Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure. JACC. Heart failure, 4(1), 68-77. https://doi.org/10.1016/j.jchf.2015.07.015
  28. 2015
  29. Grodin, J. L., Perez, A. L., Wu, Y., Hernandez, A. F., Butler, J., Metra, M., Felker, G. M., Voors, A. A., McMurray, J. J., Armstrong, P. W., Califf, R. M., Starling, R. C., O'Connor, C. M., & Tang, W. H. W. (2015). Circulating Kidney Injury Molecule-1 Levels in Acute Heart Failure Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure). JACC. Heart failure, 3(10), 777-785. https://doi.org/10.1016/j.jchf.2015.06.006
  30. Davison, B. A., Metra, M., Cotter, G., Massie, B. M., Cleland, J. G. F., Dittrich, H. C., Edwards, C., Filippatos, G., Givertz, M. M., Greenberg, B., Ponikowski, P., Voors, A. A., O'Connor, C. M., Teerlink, J. R., & PROTECT & RELAX-AHF Executive Comm (2015). Worsening Heart Failure Following Admission for Acute Heart Failure A Pooled Analysis of the PROTECT and RELAX-AHF Studies. JACC. Heart failure, 3(5), 395-403. https://doi.org/10.1016/j.jchf.2015.01.007
  31. Felker, G. M., Butler, J., Collins, S. P., Cotter, G., Davison, B. A., Ezekowitz, J. A., Filippatos, G., Levy, P. D., Metra, M., Ponikowski, P., Soergel, D. G., Teerlink, J. R., Violin, J. D., Voors, A. A., & Pang, P. S. (2015). Heart Failure Therapeutics on the Basis of a Biased Ligand of the Angiotensin-2 Type 1 Receptor Rationale and Design of the BLAST-AHF Study (Biased Ligand of the Angiotensin Receptor Study in Acute Heart Failure). JACC. Heart failure, 3(3), 193-201. https://doi.org/10.1016/j.jchf.2014.09.008
  32. Tang, W. H. W., Dupont, M., Hernandez, A. F., Voors, A. A., Hsu, A. P., Felker, G. M., Butler, J., Metra, M., Anker, S. D., Troughton, R. W., Gottlieb, S. S., McMurray, J. J., Armstrong, P. W., Massie, B. M., Califf, R. M., O'Connor, C. M., & Starling, R. C. (2015). Comparative Assessment of Short-Term Adverse Events in Acute Heart Failure With Cystatin C and Other Estimates of Renal Function: Results From the ASCEND-HF Trial. JACC. Heart failure, 3(1), 40-49. https://doi.org/10.1016/j.jchf.2014.06.014
  33. 2013
  34. Damman, K., Masson, S., Hillege, H. L., Voors, A. A., van Veldhuisen, D. J., Rossignol, P., Proietti, G., Barbuzzi, S., Nicolosi, G. L., Tavazzi, L., Maggioni, A. P., & Latini, R. (2013). Tubular Damage and Worsening Renal Function in Chronic Heart Failure. JACC. Heart failure, 1(5), 417-424. https://doi.org/10.1016/j.jchf.2013.05.007

ID: 14240803